Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan · Delayed Price · Currency is TWD 44.40
+0.05 (0.11%)
Mar 24, 2026, 1:30 PM CST
TPE:6657 Revenue
In the year 2025, Energenesis Biomedical CO.,LTD. had annual revenue of 7.67M TWD, down -0.97%. Energenesis Biomedical CO.,LTD. had revenue of 2.82M in the quarter ending December 31, 2025, with 8.44% growth.
Revenue
7.67M
Revenue Growth
-0.97%
P/S Ratio
512.95
Revenue / Employee
n/a
Employees
35
Market Cap
3.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.67M | -75.00K | -0.97% |
| Dec 31, 2024 | 7.75M | 591.00K | 8.26% |
| Dec 31, 2023 | 7.16M | -193.00K | -2.63% |
| Dec 31, 2022 | 7.35M | -138.00K | -1.84% |
| Dec 31, 2021 | 7.49M | 408.00K | 5.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medigen Biotechnology | 1.58B |
| SYN-TECH Chem. & Pharm. | 1.30B |
| Genovate Biotechnology | 492.41M |
| Sagittarius Life Science | 346.08M |
| BioGend Therapeutics | 222.34M |
| OBI Pharma | 58.58M |
| ACRO Biomedical | 36.50M |
| Shine-On BioMedical | 30.00M |